IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptorYuying Liu, Bo Huang, Yi Fang et al.|Nature Immunology|2021Cited by 374
Safety and efficacy study of oral metronomic vinorelbine combined with trastuzumab (mNH) in HER2-positive metastatic breast cancer: a phase II trialZijing Wang, Xu B, Jiaxuan Liu et al.|Breast Cancer Research and Treatment|2021Cited by 22
A randomized phase III trial comparing dose-dense epirubicin and cyclophosphamide (ECdd) followed by paclitaxel (T) with paclitaxel plus carboplatin (PCdd) as adjuvant chemotherapy for early triple-negative breast cancer patients with high-recurrence risk.Jiani Wang, Binghe Xu, Qing Li et al.|Journal of Clinical Oncology|2019Cited by 7